Title
Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood
Date Issued
01 January 2019
Access level
open access
Resource Type
journal article
Author(s)
Ten-Blanco M.
Julià-Hernández M.
Gagliano H.
Andero R.
Armario A.
Maldonado R.
Berrendero F.
Universitat Pompeu Fabra
Publisher(s)
Elsevier
Abstract
Δ 9 -tetrahydrocannabinol (THC) consumption during adolescence is reported to be a risk factor for the appearance of psychiatric disorders later in life. The interaction between genetic or environmental events and cannabinoid exposure in the adolescent period can also contribute to exacerbate behavioural deficits in adulthood. Here we investigate the effects of THC treatment as well as the consequences of concomitant THC and stress exposure during adolescence in the extinction of fear memory in adult mice. Adolescent mice treated with THC and exposed to stress exhibit impaired cued fear extinction in adulthood. However, no effect was observed in animals exposed to these two factors separately. Notably, resistance to fear extinction was associated with decreased neuronal activity in the basolateral amygdala (BLA) and the infralimbic prefrontal cortex, suggesting a long-term dysregulation of the fear circuit. These changes in neuronal activation were paralleled with structural plasticity alterations. Indeed, an increase of immature dendritic spines in pyramidal neurons of the BLA was revealed in mice simultaneously exposed to THC and stress. Corticosterone levels were also enhanced after the cued fear conditioning session in the same experimental group. These results show that an interaction between cannabis exposure and stress during adolescence may lead to long-term anxiety disorders characterized by the presence of pathological fear.
Start page
345
End page
357
Volume
144
Language
English
OCDE Knowledge area
Temas sociales Psiquiatría
Scopus EID
2-s2.0-85056639174
PubMed ID
Source
Neuropharmacology
ISSN of the container
00283908
Sponsor(s)
This work was supported by “ Plan Nacional sobre Drogas ” ( #2014I019 ) and “ Ministerio de Economía y Competitividad ” ( SAF2017-85299-R ) to FB, the " Generalitat de Catalunya-AGAUR " ( #2014-SGR-1547 ), ICREA-Acadèmia (2015) and “ Ministerio de Economía y Competitividad ” ( #SAF2017-84060-R ) to RM, NARSAD Young Investigator Grant #22434 , Ramón y Cajal program RYC2014-15784 , RETOS-MINECO SAF2016-76565-R and FEDER funds to RA , and “ Ministerio de Economía y Competitividad ” ( SAF2014-53876R ) and “ Generalitat de Catalunya ” ( SGR 2014-1020 ) to AA. Rocio Saravia is a recipient of a predoctoral fellowship from the “ Instituto de Salud Carlos III ”. We thank Raquel Martín for expert technical assistance and África Flores for her assistance in performing pilot behavioural determinations.
Sources of information: Directorio de Producción Científica Scopus